US2009247600A1PendingUtilityA1

Remedy for corneal diseases

43
Assignee: TEIKA PHARAMACEUTICAL CO LTDPriority: Aug 24, 2005Filed: Aug 24, 2006Published: Oct 1, 2009
Est. expiryAug 24, 2025(expired)· nominal 20-yr term from priority
Inventors:Takahito KimuraShigeto FujishitaHiroyoshi Kawada
A61P 37/08A61P 31/10A61P 31/04A61P 31/12A61P 27/02A61P 27/00A61P 27/04A61P 29/00A61K 31/4174C07D 233/64A61K 9/0048
43
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A therapeutic agent for a corneal disease comprising ozagrel or a salt thereof as an active ingredient is provided. The purpose is to find a substance capable of effectively treating/ameliorating a corneal disease which has been increased in the number of cases thereof in recent years and to provide a therapeutic agent for a corneal disease comprising the substance as an active ingredient.

Claims

exact text as granted — not AI-modified
1 . A therapeutic agent for a corneal disease comprising ozagrel or a salt thereof as an active ingredient. 
   
   
       2 . A therapeutic agent for a corneal disease according to  claim 1 , in the form of an ophthalmic solution. 
   
   
       3 . A therapeutic agent for a corneal disease according to either  claim 1  or  2 , being applicable to a disorder in the anterior epithelium of cornea.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.